Anika Therapeutics | ANIK - Market Capitalization


Anika Therapeutics reported $304.4M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Agenus USD 128M 21M Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 23.11B 12.19B Jun/2026
Integra LifeSciences USD 1.4B 664M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
MacroGenics USD 184M 82M Mar/2026
Merit Medical Systems USD 4.14B 25M Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026
Stryker USD 120.7B 5.15B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026
Xencor USD 1.19B 301M Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026